Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
2.766
+0.346 (14.30%)
At close: Jan 22, 2026, 4:00 PM EST
2.690
-0.076 (-2.75%)
After-hours: Jan 22, 2026, 6:05 PM EST
Xenetic Biosciences Market Cap
Xenetic Biosciences has a market cap or net worth of $6.34 million as of January 22, 2026. Its market cap has decreased by -3.98% in one year.
Market Cap
6.34M
Enterprise Value
2.18M
1-Year Change
-3.98%
Ranking
Category
Stock Price
$2.77
Market Cap Chart
Since June 30, 2016, Xenetic Biosciences's market cap has decreased from $47.70M to $6.34M, a decrease of -86.71%. That is a compound annual growth rate of -19.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 5.50M | 10.00% |
| Dec 31, 2025 | 5.00M | -19.35% |
| Dec 31, 2024 | 6.20M | 16.98% |
| Dec 29, 2023 | 5.30M | 23.26% |
| Dec 30, 2022 | 4.30M | -75.14% |
| Dec 31, 2021 | 17.30M | 35.16% |
| Dec 31, 2020 | 12.80M | 54.22% |
| Dec 31, 2019 | 8.30M | -46.10% |
| Dec 31, 2018 | 15.40M | -7.78% |
| Dec 29, 2017 | 16.70M | -53.09% |
| Dec 30, 2016 | 35.60M | -25.37% |
| Jun 30, 2016 | 47.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Processa Pharmaceuticals | 7.18M |
| Bio Green Med Solution | 6.81M |
| Genprex | 6.79M |
| Silexion Therapeutics | 6.72M |
| Acurx Pharmaceuticals | 6.53M |
| Purple Biotech | 6.52M |
| 60 Degrees Pharmaceuticals | 6.49M |
| Alaunos Therapeutics | 6.45M |